MyFinsight
Home
Blog
About
Cash and cash
equivalents
$125,172K
(2210.73%↑ Y/Y)
Prepaid expenses and
other current assets
$1,588K
(54.17%↑ Y/Y)
Accounts receivable
$500K
Total current assets
$127,260K
(1873.94%↑ Y/Y)
Restricted cash
$55K
(111.54%↑ Y/Y)
Total assets
$127,315K
(1809.63%↑ Y/Y)
Total liabilities and
stockholders' equity
$127,315K
(1809.63%↑ Y/Y)
Total stockholders'
equity
$121,748K
(4546.87%↑ Y/Y)
Total liabilities
$5,567K
(37.56%↑ Y/Y)
Accumulated deficit
-$172,899K
(-22.66%↓ Y/Y)
Additional paid-in capital
$292,910K
(104.08%↑ Y/Y)
Total current
liabilities
$5,246K
(32.14%↑ Y/Y)
Contingent consideration
obligation
$259K
(245.33%↑ Y/Y)
Derivative liability
$62K
(3000.00%↑ Y/Y)
Common stock, 0.01 par
value 450,000,000 and...
$1,735K
(3514.58%↑ Y/Y)
Series a convertible
preferred stock, 0.01 par...
$2K
(0.00%↑ Y/Y)
Accrued liabilities
$3,136K
(51.79%↑ Y/Y)
Accounts payable
$1,835K
(33.55%↑ Y/Y)
Accrued compensation
and benefits
$275K
(43.23%↑ Y/Y)
Back
Back
Balance Sheet
PALISADE BIO, INC. (PALI)
PALISADE BIO, INC. (PALI)
source: myfinsight.com